Target intelligence / Profile preview

Tumor-Associated Antigen-Presenting Dendritic Cell (TA-AP-DC)

Target
TA-AP-DC
Molecular classification
Antigen-presenting cell, Dendritic cell, Immune cell
01

Overview

Tumor-associated antigen-presenting dendritic cells (DCs) are a specialized subset of immune cells found within the tumor microenvironment (TME). They are professional antigen-presenting cells, capable of uptaking, processing, and presenting tumor antigens to naïve T cells. This function is central to initiating and regulating anti-tumor immune responses. However, their phenotype and function can be profoundly influenced by the local TME, often leading to dysfunction or tolerogenic properties that impair anti-tumor immunity. Their dual potential—to either drive effective immune attack on tumors or promote tolerance depending on environmental cues—makes them both a biomarker for prognosis and an attractive target for next-generation immunotherapies.

Other names
Tumor-infiltrating dendritic cellsIntratumoral dendritic cellsTumor-associated DCs
02

Mechanism of action

Enhancement or restoration of dendritic cell function; reprogramming resident dysfunctional/tolerogenic tumor-infiltrating dendritic cell populations

03

Biological functions

Antigen uptake and processingAntigen presentationT cell activationImmune response regulationCytokine productionMigration to lymphoid organsInduction of T cell tolerance
04

Disease associations

CancerTumor microenvironmentImmunosuppressionImmune tolerance
05

Safety considerations

Potential for inducing autoimmune responsesCytokine stormOff-target effectsTumor-induced immune suppression
06

Interacting drugs

Dendritic cell vaccines

2 more in the full profile.

07

Biomarkers

Presence of functional stimulatory intratumoral DCsAbundance of tolerogenic or suppressed DC populationscDC1 (CD141+ in humans)cDC2 (CD1c+ in humans)pDC (CD123+ in humans)

Beyond the preview

Go deeper on Tumor-Associated Antigen-Presenting Dendritic Cell (TA-AP-DC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor-Associated Antigen-Presenting Dendritic Cell (TA-AP-DC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call